Do Type 1 and Type 2 Diabetes Have the Same Vascular Complications? (original) (raw)

1.Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022;183:109119.

2.Rosenwaike I. Mortality differentials among persons born in Cuba, Mexico, and Puerto Rico residing in the United States, 1979-81. Am J Public Health 1987;77:603-6.

3.Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 2018;6:361-9.

4.Al-Majdoub M, Ali A, Storm P, Rosengren AH, Groop L, Spégel P. Metabolite profiling of LADA challenges the view of a metabolically distinct subtype. Diabetes 2017;66:806-14.

5.Hjort R, Ahlqvist E, Carlsson PO, Grill V, Groop L, Martinell M, et al. Overweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwe-gian HUNT Study. Diabetologia 2018;61:1333-43.

6.Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, et al. Differentiation of diabetes by pathophys-iology, natural history, and prognosis. Diabetes 2017;66:241-55.

7.Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.

8.Chen L, Magliano DJ, Zimmet PZ. The worldwide epi-demiology of type 2 diabetes mellitus present and future perspectives. Nat Rev Endocrinol 2011;8:228-36.

9.Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers 2017;3:17016.

10.Green A, Hede SM, Patterson CC, Wild SH, Imperatore G, Roglic G, et al. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia 2021;64:2741-50.

11.Chae HW, Seo GH, Song K, Choi HS, Suh J, Kwon A, et al. Incidence and prevalence of type 1 diabetes mellitus among Korean children and adolescents between 2007 and 2017: an epidemiologic study based on a national da-tabase. Diabetes Metab J 2020;44:866-74.

12.Thomas NJ, Lynam AL, Hill AV, Weedon MN, Shields BM, Oram RA, et al. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is com-monly treated as type 2 diabetes. Diabetologia 2019;62:1167-72.

13.Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di An-gelantonio E, et al; Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-22.

14.Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, et al. Range of risk factor levels: control, mortality, and cardiovascular outcomes in type 1 diabetes mellitus. Circulation 2017;135:1522-31.

15.Rawshani A, Sattar N, Franzén S, Rawshani A, Hattersley AT, Svensson AM, et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018;392:477-86.

16.Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 2017;376:1407-18.

17.Morton JI, Lazzarini PA, Shaw JE, Magliano DJ. Trends in the incidence of hospitalization for major diabetes-related complications in people with type 1 and type 2 diabetes in Australia, 2010-2019. Diabetes Care 2022;45:789-97.

18.Sattar N, Rawshani A, Franzén S, Rawshani A, Svensson AM, Rosengren A, et al. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation 2019;139:2228-37.

19.Constantino MI, Molyneaux L, Limacher-Gisler F, Al-Saeed A, Luo C, Wu T, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 2013;36:3863-9.

20.Dabelea D, Stafford JM, Mayer-Davis EJ, D'Agostino R Jr, Dolan L, Imperatore G, et al; SEARCH for Diabetes in Youth Research Group. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adoles-cence with complications during teenage years and young adulthood. JAMA 2017;317:825-35.

21.Luk AO, Lau ES, So WY, Ma RC, Kong AP, Ozaki R, et al. Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes. Diabetes Care 2014;37:149-57.

22.Kiss Z, Rokszin G, Abonyi-Tóth Z, Jermendy G, Kempler P, Barkai L, et al. Young adult patients with type 1 diabetes have a higher risk of mortality than those of similar age with type 2 diabetes: a nationwide analysis in Hungary. Diabetes Metab Res Rev 2019;35:e3190.

23.Shao SC, Chang KC, Hung MJ, Yang NI, Chan YY, Chen HY, et al. Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study. Cardiovasc Diabetol 2019;18:120.

24.Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, Backlund JY, et al; Writing Group for the DCCT/EDIC Research Group. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA 2015;313:45-53.

25.Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS. Deficiencies of cardiovascular risk prediction models for type 1 diabetes. Diabetes Care 2006;29:1860-5.

26.Hong YH, Chung IH, Han K, Chung S. Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Prevalence of type 2 diabetes mellitus among Korean children, adolescents, and adults younger than 30 years: changes from 2002 to 2016. Diabetes Metab J 2022;46:297-306.

27.Choi HH, Choi G, Yoon H, Ha KH, Kim DJ. Rising incidence of diabetes in young adults in South Korea: a national cohort study. Diabetes Metab J 2022;46:803-7.